Vaxart COVID-19 vaccine
Vaccine description
TargetSARS-CoV-2
Vaccine typeViral vector
Clinical data
Other namesVXA-CoV2-1, VXA-CoV2-1.1-S
Routes of
administration		Oral

Vaxart COVID-19 vaccine is a COVID-19 vaccine candidate developed by Vaxart.[1][2][3]

References

  1. ↑ Clinical trial number NCT04563702 for "Safety and Immunogenicity Trial of an Oral SARS-CoV-2 Vaccine (VXA-CoV2-1) for Prevention of COVID-19 in Healthy Adults" at ClinicalTrials.gov
  2. ↑ Clinical trial number NCT05067933 for "Ph 1b: Safety & Immunogenicity of Ad5 Based Oral Norovirus Vaccine (VXA-NVV-104)" at ClinicalTrials.gov
  3. ↑ Clinical trial number NCT05067933 for "A Ph 2 Trial With an Oral Tableted COVID-19 Vaccine" at ClinicalTrials.gov
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.